| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 667105 | 59523 | BEGLAN 25 microgramos/inhalación, suspensión para inhalación en envase a presión | BEGLAN 25 microgramos/inhalación, suspensión para inhalación en envase a presión , 1 inhalador de 120 dosis | 25 microgramos/dosis | 53 | 120 | 30 | 1 inhalador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59523/59523_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59523/59523_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1992-10-01 | 1 | 1 | 1 | 1992-10-01 | 1997-09-01 | 0 | 2011-10-10 | View Edit Delete | ||||||||||||
| 670513 | 59489 | SEREVENT ACCUHALER 50 microgramos/inhalación, polvo para inhalación | SEREVENT ACCUHALER 50 microgramos/inhalación, polvo para inhalación , 1 inhalador de 60 dosis | 50 microgramos/dosis | 53 | 60 | 8 | 1 inhalador de 60 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59489/59489_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59489/59489_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 1997-05-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 669515 | 61630 | IMIGRAN 20 mg SOLUCION PARA PULVERIZACION NASAL. | IMIGRAN 20 mg SOLUCION PARA PULVERIZACION NASAL. , 2 envases pulverizadores unidosis de 0,1 ml | 20 mg/dosis | 68 | 2 | 31 | 2 envases pulverizadores unidosis de 0,1 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61630/61630_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61630/61630_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1998-04-01 | 1 | 1 | 1 | 1998-04-01 | 1998-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 669523 | 61629 | IMIGRAN 10 mg SOLUCION PARA PULVERIZACION NASAL. | IMIGRAN 10 mg SOLUCION PARA PULVERIZACION NASAL. , 2 envases pulverizadores de 0,1 dosis | 10 mg/dosis | 68 | 2 | 31 | 2 envases pulverizadores de 0,1 dosis | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61629/61629_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61629/61629_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1998-04-01 | 1 | 1 | 1 | 1998-04-01 | 1998-04-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 668863 | 61667 | OXIS TURBUHALER 9 microgramos/INHALACION POLVO PARA INHALACION | OXIS TURBUHALER 9 microgramos/INHALACION POLVO PARA INHALACION, 1 inhalador de 60 dosis | 9 microgramos/dosis | 68 | 60 | 30 | 1 inhalador de 60 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61667/61667_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61667/61667_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42120 | LABORATORIO BETA S.A. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 668871 | 61666 | OXIS TURBUHALER 4,5 microgramos/INHALACION POLVO PARA INHALACION | OXIS TURBUHALER 4,5 microgramos/INHALACION POLVO PARA INHALACION , 1 inhalador de 60 dosis | 4,5 microgramos/dosis | 68 | 60 | 30 | 1 inhalador de 60 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61666/61666_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61666/61666_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 42120 | LABORATORIO BETA S.A. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 669629 | 72200 | SEVOFLURANO BAXTER 100% LIQUIDO PARA INHALACION DEL VAPOR EFG | SEVOFLURANO BAXTER 100% LIQUIDO PARA INHALACION DEL VAPOR EFG, 6 frascos de 250 ml | 1 ml/ml | 71 | 1500 | 26 | 6 frascos de 250 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72200/72200_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72200/72200_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2013-01-22 | 1 | 1 | 1 | 2013-01-22 | 2013-01-22 | 0 | 2013-07-15 | View Edit Delete | ||||||||||||
| 665731 | 72513 | ARALEVO 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ARALEVO 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (FRASCO) | 5 mg | 72 | 30 | 10 | 30 comprimidos (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72513/72513_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72513/72513_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2010-07-12 | 1 | 1 | 1 | 2010-07-12 | 2010-07-12 | 1 | 2011-11-28 | View Edit Delete | ||||||||||||
| 670497 | 59490 | SEREVENT 25 microgramos/inhalación, suspensión para inhalación en envase a presión | SEREVENT 25 microgramos/inhalación, suspensión para inhalación en envase a presión, 1 inhalador de 120 dosis | 25 microgramos/dosis | 86 | 120 | 30 | 1 inhalador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59490/59490_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59490/59490_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1992-07-01 | 1 | 1 | 1 | 1992-07-01 | 1997-05-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 674657 | 70932 | TAKIPRIL HIPERBARICA 20 MG/ML SOLUCION INYECTABLE | TAKIPRIL HIPERBARICA 20 MG/ML SOLUCION INYECTABLE 10 ampollas de 5 ml | 20 mg/ml inyectable 5 ml | 1 | 10 | 1 | 10 ampollas de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70932/70932_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70932/70932_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 2012-10-18 | 1 | 1 | 1 | 2012-10-18 | 2012-10-18 | 1 | 2013-09-19 | View Edit Delete | ||||||||||||
| 672066 | 67455 | DEXAMETASONA KERN PHARMA 4 mg/ml SOLUCION INYECTABLE EFG | DEXAMETASONA KERN PHARMA 4 mg/ml SOLUCION INYECTABLE EFG , 3 ampollas de 1 ml | 4 mg | 1 | 3 | 1 | 3 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67455/67455_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67455/67455_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-01-13 | 1 | 1 | 1 | 2006-01-13 | 2011-02-17 | 1 | 2012-10-10 | 653560 | View Edit Delete | |||||||||||
| 673665 | 61413 | MINURIN 4 MICROGRAMOS/ML SOLUCIÓN INYECTABLE | MINURIN 4 MICROGRAMOS/ML SOLUCIÓN INYECTABLE , 10 ampollas de 1 ml | 4 microgramos | 1 | 10 | 1 | 10 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61413/61413_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61413/61413_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31840 | FERRING S.A.U. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2011-06-28 | View Edit Delete | ||||||||||||
| 673371 | 72608 | BREVIBLOC 10 mg/ml SOLUCION PARA PERFUSION | BREVIBLOC 10 mg/ml SOLUCION PARA PERFUSION, 1 bolsa de 250 ml (Bolsa Intravia de poliolefina + dos puertos PVC + sobre bolsa de Al/Al) | 10 mg/ml inyectable 250 ml | 3 | 1 | 65 | 1 bolsa de 250 ml (Bolsa Intravia de poliolefina + dos puertos PVC + sobre bolsa de Al/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72608/72608_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72608/72608_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2011-07-21 | 1 | 1 | 1 | 2011-07-21 | 2011-07-21 | 1 | 2012-09-28 | View Edit Delete | ||||||||||||
| 672297 | 70513 | SMOFKABIVEN PERIFERICO EMULSION PARA PERFUSION | SMOFKABIVEN PERIFERICO EMULSION PARA PERFUSION , 4 bolsas de 1.448 ml | N/A (más de 4 PA) | 3 | 4 | 65 | 4 bolsas de 1.448 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70513/70513_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70513/70513_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-07-31 | 1 | 1 | 1 | 2009-07-31 | 2010-07-22 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 672582 | 70513 | SMOFKABIVEN PERIFERICO EMULSION PARA PERFUSION | SMOFKABIVEN PERIFERICO EMULSION PARA PERFUSION , 4 bolsas de 1.904 ml | N/A (más de 4 PA) | 3 | 4 | 65 | 4 bolsas de 1.904 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70513/70513_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70513/70513_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2009-07-31 | 1 | 1 | 1 | 2009-07-31 | 2010-09-27 | 1 | 2016-10-05 | View Edit Delete | ||||||||||||
| 675074 | 62713 | AGRASTAT 0,05 mg/ml SOLUCION PARA PERFUSION | AGRASTAT 0,05 mg/ml SOLUCION PARA PERFUSION , 1 bolsa de 250 ml | 50 microgramos/ml inyectable 250 ml | 3 | 1 | 65 | 1 bolsa de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62713/62713_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62713/62713_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41367 | ADVANZ PHARMA SPAIN S.L.U. | 1999-07-28 | 1 | 1 | 1 | 1999-07-28 | 2001-01-18 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 673205 | 73482 | OLANZAPINA TEVA-RATIO 5 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA TEVA-RATIO 5 mg COMPRIMIDOS BUCODISPERSABLES EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73482/73482_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73482/73482_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA GENERICOS ESPAÑOLA S.L.U. | 2011-02-09 | 1 | 1 | 1 | 2011-02-09 | 2011-08-08 | 1 | 2011-10-24 | 677433 | View Edit Delete | |||||||||||
| 675152 | 73734 | AZALIA 75 microgramos COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AZALIA 75 microgramos COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 75 microgramos | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73734/73734_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73734/73734_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8334 | GEDEON RICHTER IBERICA S.A. | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2012-12-20 | View Edit Delete | ||||||||||||
| 675158 | 73734 | AZALIA 75 microgramos COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | AZALIA 75 microgramos COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 84 (3 x 28) comprimidos | 75 microgramos | 5 | 84 | 10 | 84 (3 x 28) comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73734/73734_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73734/73734_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8334 | GEDEON RICHTER IBERICA S.A. | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2012-12-20 | View Edit Delete | ||||||||||||
| 673144 | 61132 | CRONODINE 120 mg CAPSULAS DE LIBERACION PROLONGADA | CRONODINE 120 mg CAPSULAS DE LIBERACION PROLONGADA , 60 cápsulas | 120 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61132/61132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61132/61132_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 587 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 2011-07-15 | 1 | 2011-10-04 | 785824 | View Edit Delete |
Page 247 of 1036, showing 20 records out of 20702 total, starting on record 4921, ending on 4940